Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 3/20 | 0.56 |
| ▸ | PDE4A | P27815 | 2/20 | 0.53 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.53 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.53 |
| ▸ | PPARG | P37231 | 1/20 | 0.51 |
| ▸ | PPARD | Q03181 | 1/20 | 0.51 |
| ▸ | PPARA | Q07869 | 1/20 | 0.51 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.46 |
| ▸ | TOP1 | P11387 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6055199 | 0.93 | PDE4D (0.62) | PDE4DPDE4APDE4BPDE4CPPARG | |
| SCHEMBL5492854 | 0.88 | PDE4D (0.64) | PDE4DPDE4APDE4BPDE4CPPARG | |
| SCHEMBL15194927 | 0.86 | PDE4D (0.47) | PDE4DPDE4APDE4BPDE4CHTR1A | |
| SCHEMBL10335590 | 0.86 | PPARG (0.61) | PDE4DPDE4APDE4BPDE4CPPARG | |
| SCHEMBL28550136 | 0.86 | CYP3A4 (0.67) | HTR1ACYP3A4TSHRNFKB1BLM | |
| SCHEMBL27107627 | 0.84 | NR1I2 (0.50) | PDE4DPPARGPPARDPPARAHTR1A | |
| SCHEMBL27570423 | 0.83 | PDE4D (0.48) | PDE4DPDE4APDE4BPDE4CPPARG | |
| SCHEMBL6055371 | 0.83 | PPARG (0.61) | PDE4DPDE4APDE4BPDE4CPPARG | |
| SCHEMBL12898700 | 0.83 | SLC2A1 (0.54) | PPARGPPARDPPARAHTR1AEPHX2 | |
| SCHEMBL7465208 | 0.83 | PPARG (0.43) | PDE4DPPARGPPARDPPARAHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12060538-B2 | Cleavable surfactants | PROMEGA CORPORATION (US) | 2024-08-13 | — | — | US | disclosed |
| US-20230183603-A1 | CLEAVABLE SURFACTANTS | PROMEGA CORPORATION | 2023-06-15 | — | — | US | disclosed |
| US-11624041-B2 | Cleavable surfactants | PROMEGA CORPORATION (US) | 2023-04-11 | — | — | US | disclosed |
| US-20200263110-A1 | CLEAVABLE SURFACTANTS | PROMEGA CORPORATION | 2020-08-20 | — | — | US | disclosed |
| US-10626349-B2 | Cleavable surfactants | PROMEGA CORPORATION (US) | 2020-04-21 | — | — | US | disclosed |
| US-20180187127-A1 | CLEAVABLE SURFACTANTS | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2018-07-05 | — | — | US | disclosed |
| US-9816054-B2 | Cleavable surfactants | PROMEGA CORPORATION (US) | 2017-11-14 | — | — | US | disclosed |
| EP-2584027-B1 | Cleavable surfactants | PROMEGA CORP (US) | 2015-12-30 | — | — | EP | disclosed |
| EP-2584027-A2 | Cleavable surfactants | Promega Corporation (US) | 2013-04-24 | — | — | EP | disclosed |
| EP-2197996-B1 | CLEAVABLE SURFACTANTS | PROMEGA CORP (US) | 2012-12-05 | — | — | EP | disclosed |
| EP-2197996-A2 | CLEAVABLE SURFACTANTS | Promega Corporation (US) | 2010-06-23 | — | — | EP | disclosed |
| WO-2009048611-A2 | CLEAVABLE SURFACTANTS | PROMEGA CORPORATION (US) | 2009-04-16 | — | — | WO | disclosed |
| US-20090095628-A1 | CLEAVABLE SURFACTANTS | PROMEGA CORPORATION (US) | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200263110-A1 | CLEAVABLE SURFACTANTS | SI, PRSS3, TMPRSS15 | PDE4D 3003/4885PDE4A 2726/4885PDE4B 2921/4885 |
| US-11624041-B2 | Cleavable surfactants | SI, PRSS3, TMPRSS15 | PDE4D 3003/4885PDE4A 2726/4885PDE4B 2921/4885 |
| US-12060538-B2 | Cleavable surfactants | SI, PRSS3, TMPRSS15 | PDE4D 3003/4885PDE4A 2726/4885PDE4B 2921/4885 |
| US-20180187127-A1 | CLEAVABLE SURFACTANTS | SI, PRSS3, TMPRSS15 | PDE4D 3003/4885PDE4A 2726/4885PDE4B 2921/4885 |
| US-10626349-B2 | Cleavable surfactants | SI, PRSS3, TMPRSS15 | PDE4D 3003/4885PDE4A 2726/4885PDE4B 2921/4885 |
| US-20090095628-A1 | CLEAVABLE SURFACTANTS | SI, PRSS3, TMPRSS15 | PDE4D 3003/4885PDE4A 2726/4885PDE4B 2921/4885 |
| US-20230183603-A1 | CLEAVABLE SURFACTANTS | SI, PRSS3, TMPRSS15 | PDE4D 3003/4885PDE4A 2726/4885PDE4B 2921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.